Metabopath Liquid
NDC Package 64578-0102-1
Package Information
Metabopath (adenosinum cyclophosphoricum, adenosinum triphosphoricum dinatrum, alpha-ketoglutaricum acidum, berberis vulgaris, citricum acidum, coenzyme a, dna, fumaricum acidum, glycyrrhiza glabra, hepar sulphuris calcareum, lappa major, magnesia phosphorica, manganum aceticum, nadidum, natrum muriaticum, natrum oxalaceticum, natrum pyruvicum, nicotinamidum, pulsatilla, pyridoxinum hydrochloricum, rhamnus purshiana, riboflavinum, rna, silicea, succinicum acidum, sulphur, thiaminum hydrochloricum,) liquids is classified as a
- acidifying activity - [moa] (mechanism of action)
- allergens - [cs]
- analogs/derivatives - [chemical/ingredient]
- anti-coagulant - [epc] (established pharmacologic class)
- calcium chelating activity - [moa] (mechanism of action)
- calculi dissolution agent - [epc] (established pharmacologic class)
- cell-mediated immunity - [pe] (physiologic effect)
- copper absorption inhibitor - [epc] (established pharmacologic class)
- decreased coagulation factor activity - [pe] (physiologic effect)
- decreased copper ion absorption - [pe] (physiologic effect)
- dietary proteins - [cs]
- increased histamine release - [pe] (physiologic effect)
- magnetic resonance contrast activity - [moa] (mechanism of action)
- non-standardized food allergenic extract - [epc] (established pharmacologic class)
- non-standardized plant allergenic extract - [epc] (established pharmacologic class)
- paramagnetic contrast agent - [epc] (established pharmacologic class)
- plant proteins - [cs]
- vitamin b 6 - [chemical/ingredient]
- vitamin b6 analog - [epc] (established pharmacologic class)
Identification & Billing
Clinical Specifications
- ADENOSINE CYCLIC PHOSPHATE 8 [hp_X]/mL
- .ALPHA.-KETOGLUTARIC ACID 12 [hp_X]/mL
- ADENOSINE TRIPHOSPHATE DISODIUM 12 [hp_X]/mL
- BERBERIS VULGARIS ROOT BARK 4 [hp_X]/mL
- ANHYDROUS CITRIC ACID 8 [hp_X]/mL
- COENZYME A 12 [hp_X]/mL
- HERRING SPERM DNA 30 [hp_X]/mL
- FUMARIC ACID 12 [hp_X]/mL
- GLYCYRRHIZA GLABRA 4 [hp_X]/mL
- CALCIUM SULFIDE 30 [hp_X]/mL
- ARCTIUM LAPPA ROOT 4 [hp_X]/mL
- MAGNESIUM PHOSPHATE, DIBASIC 12 [hp_X]/mL
- MANGANESE ACETATE TETRAHYDRATE 10 [hp_X]/mL
- NADIDE 12 [hp_X]/mL
- SODIUM CHLORIDE 12 [hp_X]/mL
- SODIUM DIETHYL OXALACETATE 12 [hp_X]/mL
- SODIUM PYRUVATE 12 [hp_X]/mL
- NIACINAMIDE 6 [hp_X]/mL
- PULSATILLA VULGARIS 12 [hp_X]/mL
- PYRIDOXINE HYDROCHLORIDE 6 [hp_X]/mL
- FRANGULA PURSHIANA BARK 4 [hp_X]/mL
- RIBOFLAVIN 10 [hp_X]/mL
- SACCHAROMYCES CEREVISIAE RNA 30 [hp_X]/mL
- SILICON DIOXIDE 12 [hp_X]/mL
- SUCCINIC ACID 12 [hp_X]/mL
- SULFUR 12 [hp_X]/mL
- THIAMINE HYDROCHLORIDE 6 [hp_X]/mL
- THYROID, BOVINE 9 [hp_X]/mL
- TRIFOLIUM PRATENSE FLOWER 4 [hp_X]/mL
- ZANTHOXYLUM AMERICANUM BARK 4 [hp_X]/mL
- ZINC GLUCONATE 10 [hp_X]/mL
- Acidifying Activity - [MoA] (Mechanism of Action)
- Allergens - [CS]
- Analogs/Derivatives - [Chemical/Ingredient]
- Anti-coagulant - [EPC] (Established Pharmacologic Class)
- Calcium Chelating Activity - [MoA] (Mechanism of Action)
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Copper Absorption Inhibitor - [EPC] (Established Pharmacologic Class)
- Decreased Coagulation Factor Activity - [PE] (Physiologic Effect)
- Decreased Copper Ion Absorption - [PE] (Physiologic Effect)
- Dietary Proteins - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Magnetic Resonance Contrast Activity - [MoA] (Mechanism of Action)
- Non-Standardized Food Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Paramagnetic Contrast Agent - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Vitamin B 6 - [Chemical/Ingredient]
- Vitamin B6 Analog - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 64578 - Energetix Corporation
- 64578-0102 - Metabopath
- 64578-0102-1 - 59.1 mL in 1 BOTTLE, DROPPER
- 64578-0102 - Metabopath
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 64578-0102-1 identifies a specific commercial package of 59.1 ml in 1 bottle, dropper of Metabopath, a human over the counter drug labeled by Energetix Corporation. This liquid is formulated for oral use and contains adenosine cyclic phosphate; .alpha.-ketoglutaric acid; adenosine triphosphate disodium; berberis vulgaris root bark; anhydrous citric acid; coenzyme a; herring sperm dna; fumaric acid; glycyrrhiza glabra; calcium sulfide; arctium lappa root; magnesium phosphate, dibasic; manganese acetate tetrahydrate; nadide; sodium chloride; sodium diethyl oxalacetate; sodium pyruvate; niacinamide; pulsatilla vulgaris; pyridoxine hydrochloride; frangula purshiana bark; riboflavin; saccharomyces cerevisiae rna; silicon dioxide; succinic acid; sulfur; thiamine hydrochloride; thyroid, bovine; trifolium pratense flower; zanthoxylum americanum bark; zinc gluconate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Energetix Corporation on August 08, 2014. The current certification is valid through December 31, 2027.
How is this Energetix Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 64578010201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.